Up and Coming
This feature highlights changes in clinical trial organizations’ personnel.
Former chief commercial officer at Kite Pharma, Michael Amoroso, has been named chief operating officer of Abeona Therapeutics.
Adicet Bio has appointed Don Healey to the role of chief technology officer. Previously, Healey served as senior vice president of operations at KBI Biopharma.
Apilli Therapeutics has found its new chief development officer in Don Cilla. Cilla has held previous development roles at Shire, MedImmune and Otsuka America.
Mina Pastagia has been appointed vice president of clinical development of Armata Pharmaceuticals. Pastagia was most recently senior medical director of infectious diseases and vaccines at Janssen Biopharma.
Christian Rommel has been appointed head of pharmaceuticals at Bayer. Rommel’s prior position was that of senior vice president and global head of oncology research and early development at Hoffmann-La Roche.
Patrick Kaltenbach has become Becton, Dickinson’s (BD) new executive vice president and chief technology officer. Kaltenbach was most recently the executive vice president and president of the life sciences segment at BD.
Yunxiang Zhu, former senior vice president of Shenogen Pharma Group, has been appointed head of global research at CANbridge Pharmaceuticals.
James Aggen has been named Circle Pharma’s vice president of medicinal chemistry. Most recently, Aggen was senior director of medicinal chemistry at Revolution Medicines.
Cogent Biosciences has found its new CEO in Andrew Robbins, the former chief operating officer of Array Biopharma.
Mark Kirschbaum has been appointed to the role of chief medical officer of Cyclacel Pharmaceuticals. Prior to this appointment, Kirschbaum served as vice president of hematology/oncology at ArQule.
Chris Min has been appointed to the position of vice president and head of medical and clinical development at Enterin. Min most recently held the position of head of clinical pharmacology at Cerevel Therapeutics.
ERYTECH Pharma has hired Stewart Craig, former chief manufacturing officer of Orchard Therapeutics, to fill the role of chief technology officer.
William Fanslow has been named senior vice president of drug development at Fibrocor Therapeutics. Most recently, Fanslow was executive vice president of research and development at Sound Biologics.
Catherine Thut has been named chief business officer of GentiBio. Previously, Thut was CEO of Makana Therapeutics. GentiBio has also appointed Thomas Wickham to the role of chief scientific officer. Wickham most recently held the position of senior vice president of research and development at Rubius Therapeutics.
Steven Yecies has joined Javelin Oncology as its CEO. Yecies takes the helm of Javelin while also serving as managing partner of New Dimensions Health Fund as well as several board member positions at other healthcare companies.
Monte Rosa Therapeutics
Precision medicine biotech Monte Rosa Therapeutics has appointed Min Wang to the role of chief operating officer. Wang is the former chief operating officer of BlueRock Therapeutics. Monte Rosa Therapeutics has also named Jullian Jones as senior vice president and head of business development. Jones was most recently senior director of oncology business development at Eli Lilly.
NantKwest has named Richard Adcock CEO of the company. Most recently, Adcock was CEO of Verity Health Systems.
Nick Nelson has been named chief business officer of Nautilus Biotechnology. Nelson was formerly the chief business officer of Caris Life Sciences.
Redx Pharma has named Jane Robertson chief medical officer of the company. Previously, Robertson was chief medical officer at Achilles Therapeutics.
Paolo Manfredi has been named acting chief scientific officer of Relmada Therapeutics. Previously, Manfredi was scientific director of Medeor, a company he co-founded. Relmada Therapeutics has also named Marco Pappagallo acting chief medical officer. Pappagallo most recently served as chief medical officer of CerSci Therapeutics.
Jennifer Chien has been named executive vice president and head of North America at Rhythm Pharmaceuticals. Recently, Chien was chief commercial officer at Krystal Biotech.
Biotech company Sapreme has appointed Miriam Bujny to the role of chief development officer. Formerly, Bujny was senior director of R&D at ProQR Therapeutics.
Wayne Saville has been named chief medical officer of Shasqi. Most recently, Saville was vice president of oncology clinical development at Xencor.
Milan Zdravkovic has been named chief medical officer of Snipr Biome. Zdravkovic was formerly chief medical officer and head of R&D of Orphan Biovitrum.
William Schwieterman has been appointed CEO of Stream Biomedical. Most recently, Schwieterman was the CEO of NeuMedics.
Synklino has named Josefin-Beate Holz chief medical officer. Holz is also the chief medical officer for STORM Therapeutics.
TriSalus Life Sciences
TriSalus Life Sciences has appointed Trevor McCaw chief commercial officer. Most recently, McCaw was president and chief commercial officer of Clerio Vision.
Vaccitech has hired Margaret Marshall to the role of chief medical officer. Marshall joins Vaccitech full-time after working as a consultant with the company.
Vigene Biosciences has named Audrey Chang vice president of quality control and analytical services. Chang most recently served in an executive position at BioReliance, where she led quality control development efforts for cell gene therapy.